Last reviewed · How we verify
Control (bupivacaine) — Competitive Intelligence Brief
marketed
Local anesthetic (amide)
Voltage-gated sodium channels
Anesthesia
Small molecule
Live · refreshed every 30 min
Target snapshot
Control (bupivacaine) (Control (bupivacaine)) — Kasr El Aini Hospital. Bupivacaine blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials to produce local anesthesia.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Control (bupivacaine) TARGET | Control (bupivacaine) | Kasr El Aini Hospital | marketed | Local anesthetic (amide) | Voltage-gated sodium channels | |
| intraarticular injection with ropivacaine | intraarticular injection with ropivacaine | Hvidovre University Hospital | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Exparel/bupivacaine mixture | Exparel/bupivacaine mixture | Wake Forest University Health Sciences | marketed | Local anesthetic (liposomal formulation) | Voltage-gated sodium channels | |
| Ropivacaine 0,75% in PENG block | Ropivacaine 0,75% in PENG block | University of Liege | marketed | Local anesthetic (amide) | Voltage-gated sodium channels | |
| liposomal bupivacaine local infiltration | liposomal bupivacaine local infiltration | Second Affiliated Hospital, School of Medicine, Zhejiang University | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Compound lidocaine | Compound lidocaine | Tianjin Medical University General Hospital | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Tegretol® | Tegretol® | University of Malaya | marketed | Anticonvulsant; mood stabilizer | Voltage-gated sodium channels |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic (amide) class)
- Poznan University of Medical Sciences · 4 drugs in this class
- Nantes University Hospital · 3 drugs in this class
- Bozyaka Training and Research Hospital · 2 drugs in this class
- ASST Gaetano Pini-CTO · 2 drugs in this class
- Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
- Chiang Mai University · 1 drug in this class
- Beijing Tiantan Hospital · 1 drug in this class
- Complejo Hospitalario Universitario de Granada · 1 drug in this class
- Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
- China Medical University, China · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Control (bupivacaine) CI watch — RSS
- Control (bupivacaine) CI watch — Atom
- Control (bupivacaine) CI watch — JSON
- Control (bupivacaine) alone — RSS
- Whole Local anesthetic (amide) class — RSS
Cite this brief
Drug Landscape (2026). Control (bupivacaine) — Competitive Intelligence Brief. https://druglandscape.com/ci/control-bupivacaine. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing